aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Lucence, a precision oncology company, was founded with the mission to bring clarity to cancer care through innovative diagnostics. The company specializes in developing ultrasensitive non-invasive liquid biopsy tests, which provide crucial information for the early detection and effective treatment of cancer. Lucence aims to redefine the future of early cancer detection by creating advanced blood-testing technologies that are both accurate and affordable, targeting a global market of healthcare providers and patients.
Notable figures affiliated with Lucence include its founder and key investors who have supported its growth. The company has achieved significant milestones, including the development and commercialization of its LiquidHALLMARK® multi-cancer screening test. Lucence's work has had a profound impact on the field of oncology, offering new hope for earlier cancer diagnosis and improved patient outcomes.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Liquid Biopsy
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Lucence founded?
Lucence was founded in 2016.
Where is Lucence’s headquarters located?
Lucence’s headquarters is located in Palo Alto, CA, US.
When was Lucence’s last funding round?
Lucence’s most recent funding round was for $20M (USD) in November 2019.
How many employees does Lucence have?
Lucence has 85 employees as of Feb 4, 2024.
How much has Lucence raised to-date?
As of July 05, 2023, Lucence has raised a total of $29.2M (USD) since Nov 20, 2019.
Add Comparison
Total Raised to Date
$29.2M
USD
Last Update Nov 20, 2019
Last Deal Details
$20M
USD
Nov 20, 2019
Series A
Total Employees Over Time
85
As of Feb 2024
Lucence Address
3520 W Bayshore Rd
Palo Alto,
California
943034228
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts